Health and Fitness

Blumenauer and Rohrabacher

Rohrabacher-Blumenauer Medical Cannabis Protections Temporarily Extended

Washington, DC–(ENEWSPF)–September 15, 2017. President Donald Trump reached an agreement late last week with Congressional leadership to enact a three-month continuing resolution that maintains present federal spending levels and priorities through December 8, 2017. The resolution extends medical cannabis patient protections imposed by the Rohrabacher-Blumenauer amendment until that date. The[Read More…]

Blood Stained Men

Human Rights Activists to Protest American Academy of Pediatrics’ Harmful Exploitative Circumcision Policy

Chicago, IL –(ENEWSPF)–September 15, 2017.  No one should alter the body of an un-consenting person without acute medical need. The Bloodstained Men and Their Friends will be sharing this message while protesting the American Academy of Pediatrics (AAP) at its annual conference this weekend at McCormick Place Convention Center in[Read More…]

FDA

FDA Approves New Treatment for Adults with Relapsed Follicular Lymphoma

Silver Spring, Maryland–(ENEWSPF)–September 14, 2017. The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies. “For patients with relapsed follicular lymphoma, the cancer often comes back[Read More…]

Reset device by Pear Therapeutics

FDA Permits Marketing of Mobile Medical Application for Substance Use Disorder

Silver Spring, Maryland–(ENEWSPF)–September 14, 2017. Today, the U.S. Food and Drug Administration permitted marketing of the first mobile medical application to help treat substance use disorders (SUD). The Reset application is intended to be used with outpatient therapy to treat alcohol, cocaine, marijuana and stimulant SUDs. The application is not[Read More…]

FDA

FDA Approves First Biosimilar for the Treatment of Cancer

Mvasi, a biosimilar to the cancer drug Avastin, is approved for certain colorectal, lung, brain, kidney and cervical cancers Silver Spring, Maryland–(ENEWSPF)–September 14, 2017. The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is[Read More…]

Healty pets

Multistate Outbreak of Human Campylobacter Infections Linked to Pet Store Puppies

Atlanta, GA–(ENEWSPF)–September 11, 2017. The Ohio Department of Health, several other states, CDC, and USDA-APHIS are investigating a multistate outbreak of human Campylobacter infections linked to puppies sold through Petland stores. Investigators are looking for the source of infections in people and puppies so they can recommend how to stop[Read More…]

Most read stories this week

Take a Survey

ARCHIVES